Coronavirus / COVID-19 Pandemic Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Investor2

From: i-node	7/29/2020 1:04:41 AM
	1 Recommendation Read Replies (1) of 22868

This from an article on Lindy's thread earlier today. Not a formal study, but Hydroxychloroquine is shown to be effective in a large sample within India, including prophylactic use: 100,000 patients sampled who were close contacts of positive individuals. 48,873 took one dose 102 became sick 12 died 17,776 took two doses 48 became sick 1 died 33,563 took three doses 43 became sick 1 died “The task force of medical experts, including physicians and super specialists, have recommend and backed the drive to administer HCQ in cluster areas and high exposure cases. We have discussed the analysis and the results with the government. The benefits seem to far outweigh the debate around its risks and it has certainly helped in implementing the preventive strategies planned for the city,” Rao said. indianexpress.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next